Description

Fromilid UNO tablets with modified release 500 mg. №7

Ingredients:

Each tablet contains 500 mg of modified release clarithromycin.

Dosage:

The recommended dosage is one tablet once daily. It is important to follow the instructions of your healthcare provider.

Indications:

Fromilid UNO tablets are indicated for the treatment of bacterial infections. They are commonly prescribed for respiratory tract infections, skin and soft tissue infections, and Helicobacter pylori eradication in peptic ulcer disease.

Contraindications:

Do not take Fromilid UNO if you are allergic to clarithromycin or other macrolide antibiotics. It is important to inform your doctor about any allergies or medical conditions before starting this medication.

Directions:

Swallow the tablet whole with a glass of water, do not crush or chew it. It is best to take it at the same time each day to maintain a consistent level of the drug in your body.

Scientific Evidence:

Studies have shown the efficacy of clarithromycin in treating various bacterial infections. Research published in the International Journal of Antimicrobial Agents demonstrated the effectiveness of clarithromycin in the treatment of community-acquired pneumonia.

Additional Information:

It is important to complete the full course of treatment with Fromilid UNO tablets as prescribed by your healthcare provider. If you experience any severe side effects or allergic reactions, seek medical attention immediately.

Fromilid UNO tablets with modified release 500 mg provide a convenient once-daily dosing option for patients requiring treatment for bacterial infections. The modified release formulation ensures a steady concentration of the drug in the body, enhancing its effectiveness.

The pharmacological action of clarithromycin involves inhibiting bacterial protein synthesis, leading to the eradication of susceptible bacteria. This mechanism of action makes it a valuable agent in the treatment of a wide range of infections.